2 Tiger Global Novo Nordisk Trades
Tiger Global started to build up the position in Novo Nordisk in Q2 2023. Since then they sold 1.27M shares. The investor sold all their shares in Q3 2025 and doesn't own any shares in Novo Nordisk anymore.
News about Novo Nordisk - ADR and Tiger Global
Novo Nordisk: Full Kitchen Sink Reset Or Another Shoe Yet To Drop?
Novo Nordisk A/S shares plunged ~25% after sharply lowered 2026 revenue and profit guidance, driven by unexpectedly steep US price declines and competitive p...
Generic Ozempic Will Upend the Global Weight-Loss Drug Market
Novo Nordisk is predicting a 13% drop in sales in 2026. As the company's patents on Ozempic expire, could cheaper, generic versions give the company a run fo...
Crypto ETPs defy market weakness, post $164B in AUM for 2025: Fineqia analysis
Global digital asset Exchange Traded Products (ETPs) ended 2025 on a high note, with total assets under management (AUM) rising 8.8% to $164.2 billion...
3 Weight-Loss Drug Stocks To Consider For 2026
The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it's set to expand from $15 billion in 2024 to $150...